临床案例 / 真实世界数据

吾谷灵™五谷虫案例一则（HPV感染—乳腺结节）

吾谷灵™临床数据中心发布日期 2024约 8 分钟阅读

关键数据一览

阴性

高危 HPV-52

完全清除

E6/E7 mRNA 阴性

3类BI-RADS

乳腺结节风险

降级缩小

4a类 → 3类

患者基本情况

黄女士，48岁，2023年8月开始服用吾谷灵™五谷虫。

HPV 感染对比

服药前：2021、2023年高危 HPV-52 型持续感染2年。服药后（2025年2月）：高危型 HPV（含52型）全部阴性，E6/E7 mRNA 阴性，宫颈细胞未发生癌前病变分子标志物变化。

乳腺健康对比

服药前（2023年6月）：双乳多发结节，BI-RADS 4a类，最大结节0.9×0.9×0.4 cm。服药后（2025年2月）：降至 BI-RADS 3类，左乳结节缩小至0.5×0.2 cm。

机制分析

五谷虫蛋白富含氨基酸与生物活性物质，增强机体免疫力（NK细胞、T细胞活性），加速 HPV 清除、降低结节恶性风险。

个案仅供参考，不构成医疗建议。

医学报告与数据

重要声明：本页面为吾谷灵™五谷虫真实世界辅助调理个案整理，仅供学术交流参考，不构成医疗建议，不能替代手术、放疗、化疗等标准抗肿瘤治疗。个案结果因人而异，具体用药请遵医嘱。

Clinical Cases / Real-world Data

Vogreen Medicinal Housefly Larvae Case (HPV Infection & Breast Nodules)

Vogreen Clinical Data CenterReleased 2024About 8 min read

Key Data Overview

Negative

High-risk HPV-52

Completely cleared

E6/E7 mRNA negative

Class 3BI-RADS

Breast Nodule Risk

Downgraded & shrank

4a → 3

Case Summary

A 48-year-old female took Vogreen Medicinal Housefly Larvae from August 2023. After medication, her 2-year persistent high-risk HPV-52 turned negative (E6/E7 mRNA negative), and breast nodules were downgraded from BI-RADS 4a to 3 with shrinkage. Vogreen protein enhances immunity (NK and T cell activity), accelerating HPV clearance. For reference only, not medical advice.

Key Data & Reports

Please refer to the medical reports and data charts below for detailed examination results and imaging records.

Medical Reports & Data

HPV nucleic acid test report — high-risk turned negative

Breast ultrasound re-examination — nodule shrinkage and downgrade

Disclaimer: This page documents a real-world adjuvant care case of Vogreen Medicinal Housefly Larvae for academic exchange only. It does not constitute medical advice and cannot replace standard anti-tumor treatments such as surgery, radiotherapy or chemotherapy. Individual results vary. Please follow your physician's guidance.